Literature DB >> 19841782

Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn(II).

Rok Sekirnik1, Nathan R Rose, Armin Thalhammer, Peter T Seden, Jasmin Mecinović, Christopher J Schofield.   

Abstract

JMJD2A, a 2-oxoglutarate dependent N(epsilon)-methyl lysine histone demethylase, is inhibited by disruption of its Zn-binding site by Zn-ejecting compounds including disulfiram and ebselen; this observation may enable the development of inhibitors selective for this subfamily of 2OG dependent oxygenases that do not rely on binding to the highly-conserved Fe(ii)-containing active site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841782     DOI: 10.1039/b916357c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  30 in total

Review 1.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

Review 2.  Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.

Authors:  Zhanxin Wang; Dinshaw J Patel
Journal:  Q Rev Biophys       Date:  2013-09-02       Impact factor: 5.318

3.  Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.

Authors:  Roselyne M Labbé; Andreana Holowatyj; Zeng-Quan Yang
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

4.  Activity-dependent Regulation of Histone Lysine Demethylase KDM1A by a Putative Thiol/Disulfide Switch.

Authors:  Emily L Ricq; Jacob M Hooker; Stephen J Haggarty
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

5.  Inhibition of histone demethylases by 4-carboxy-2,2'-bipyridyl compounds.

Authors:  Kai-Hsuan Chang; Oliver N F King; Anthony Tumber; Esther C Y Woon; Tom D Heightman; Michael A McDonough; Christopher J Schofield; Nathan R Rose
Journal:  ChemMedChem       Date:  2011-03-15       Impact factor: 3.466

Review 6.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

7.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Authors:  Dante Rotili; Antonello Mai
Journal:  Genes Cancer       Date:  2011-06

Review 8.  Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.

Authors:  Emily L Ricq; Jacob M Hooker; Stephen J Haggarty
Journal:  Psychiatry Clin Neurosci       Date:  2016-09-07       Impact factor: 5.188

9.  A method to site-specifically introduce methyllysine into proteins in E. coli.

Authors:  Hui-Wang Ai; Jae Wook Lee; Peter G Schultz
Journal:  Chem Commun (Camb)       Date:  2010-06-22       Impact factor: 6.222

10.  Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity.

Authors:  Hyo Jeong Lee; Bo-Kyoung Kim; Kyoung Bin Yoon; Yong-Chul Kim; Sun-Young Han
Journal:  Invest New Drugs       Date:  2017-09-14       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.